Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$1.02 - $1.83 $103,971 - $186,537
-101,933 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$1.06 - $2.1 $11,780 - $23,339
-11,114 Reduced 9.83%
101,933 $144,000
Q4 2021

Feb 11, 2022

BUY
$2.05 - $3.2 $11,350 - $17,718
5,537 Added 5.15%
113,047 $232,000
Q3 2021

Nov 04, 2021

SELL
$2.54 - $4.07 $34,724 - $55,640
-13,671 Reduced 11.28%
107,510 $331,000
Q2 2021

Aug 11, 2021

BUY
$2.57 - $4.85 $20,277 - $38,266
7,890 Added 6.96%
121,181 $494,000
Q1 2021

May 13, 2021

SELL
$1.9 - $2.82 $19,733 - $29,288
-10,386 Reduced 8.4%
113,291 $279,000
Q4 2020

Feb 16, 2021

BUY
$1.15 - $2.4 $15,653 - $32,668
13,612 Added 12.37%
123,677 $263,000
Q3 2020

Nov 12, 2020

BUY
$1.11 - $1.68 $34,174 - $51,723
30,788 Added 38.84%
110,065 $134,000
Q2 2020

Aug 13, 2020

BUY
$1.69 - $4.2 $133,978 - $332,963
79,277 New
79,277 $136,000
Q1 2020

May 14, 2020

SELL
$1.26 - $3.38 $47,354 - $127,030
-37,583 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$0.86 - $1.44 $32,321 - $54,119
37,583 New
37,583 $50,000
Q3 2019

Nov 14, 2019

SELL
$1.21 - $1.59 $1.06 Million - $1.39 Million
-871,938 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$1.25 - $3.14 $859,948 - $2.16 Million
-687,959 Reduced 44.1%
871,938 $1.32 Million
Q1 2019

May 15, 2019

BUY
$2.79 - $4.09 $2.81 Million - $4.12 Million
1,006,448 Added 181.85%
1,559,897 $4.62 Million
Q4 2018

Feb 14, 2019

BUY
$3.23 - $7.01 $367,916 - $798,481
113,906 Added 25.91%
553,449 $1.86 Million
Q3 2018

Dec 21, 2021

BUY
$6.86 - $9.97 $2.02 Million - $2.93 Million
294,069 Added 202.15%
439,543 $3.19 Million
Q3 2018

Nov 14, 2018

BUY
$6.86 - $9.97 $303,143 - $440,574
44,190 Added 43.63%
145,474 $1.05 Million
Q2 2018

Apr 21, 2020

BUY
$2.88 - $8.67 $49,409 - $148,742
17,156 Added 20.39%
101,284 $696,000
Q2 2018

Aug 14, 2018

BUY
$2.88 - $8.67 $147,479 - $443,973
51,208 Added 155.55%
84,128 $578,000
Q1 2018

May 15, 2018

SELL
$2.92 - $3.81 $49,164 - $64,148
-16,837 Reduced 33.84%
32,920 $98,000
Q4 2017

Feb 14, 2018

SELL
$2.99 - $4.85 $522,753 - $847,944
-174,834 Reduced 77.85%
49,757 $152,000
Q3 2017

Nov 14, 2017

BUY
$3.01 - $5.41 $676,018 - $1.22 Million
224,591
224,591 $1.06 Million

Others Institutions Holding VSTM

About Verastem, Inc.


  • Ticker VSTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 210,000,000
  • Market Cap $840M
  • Description
  • Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...
More about VSTM
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.